All Infection Prevention & Control articles – Page 7
-
NewsNewly discovered host mechanism in coronaviruses
A previously unknown cellular mechanism crucial to the replication of coronaviruses has been identified: c-Jun N-terminal kinase (JNK) is activated during infection with human coronavirus HCoV-229E and mediates the phosphorylation of the viral nucleocapsid (N) protein.
-
NewsEvolving antibiotic resistance under pressure may lead to personalized treatment
A new study demonstrates the use of an experimental evolution approach to map genetic mutations in Acinetobacter baumannii treated with one of two uncommon antibiotics.
-
NewsNew nasal vaccine has potential to transform respiratory disease prevention
Researchers have demonstrated that their nasally-delivered, antibiotic-inactivated Bordetella pertussis (AIBP) vaccine not only prevents severe disease but also curbs bacterial transmission — an achievement long sought by vaccine developers worldwide.
-
NewsBiochemists search for cellular vulnerabilities in killer ‘superbugs’
Helen Zgurskaya and Valentin Rybenkov are leading a five-year, $5.3 million project funded by the National Institute of Allergy and Infectious Diseases to find new ways to deliver lifesaving drugs directly into resistant pathogens.
-
NewsTemporary benefit for immune system in early HIV treatment, but dysregulation returns
A study investigated whether immune dysregulation can be prevented by starting HIV medication immediately after infection. Six months after this early treatment, the immune system did indeed work as in people without HIV, but in the longer term, the immune system was disrupted again.
-
NewsCOVID-19 vaccination linked to reduced infections in children with eczema
Children with atopic dermatitis (AD), commonly known as eczema, may experience fewer infections and allergic complications if they receive the COVID-19 vaccine, according to new research.
-
NewsScientists uncover tuberculosis bacterium’s ’heartbeat’, opening door to new treatments
Scientists have identified a molecular system inside Mycobacterium tuberculosis that functions like the organism’s heart or lungs, keeping it alive. The system, known as PrrAB, helps the bacterium generate energy and breathe. When researchers used a gene-silencing tool, the bacterium died.
-
NewsNot just a common cold: studies show RSV’s severity and impact on long-term health
Often confused for a common cold, respiratory syncytial virus (RSV) can in fact be serious and should be studied more closely. Researchers found that the illness could be of comparable severity to other more well-known respiratory viral infections (RVIs) – such as influenza and COVID-19.
-
NewsAI can speed antibody design to thwart novel viruses: study
Artificial intelligence (AI) and “protein language” models can speed the design of monoclonal antibodies that prevent or reduce the severity of potentially life-threatening viral infections, according to a multi-institutional study
-
NewsNew study finds targets for a new tuberculosis vaccine
A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world’s deadliest infectious disease.
-
NewsResearchers capture first high-res images of deadly yellow fever virus
Researchers have captured the first high-resolution images of the yellow fever virus (YFV), a potentially deadly viral disease transmitted by mosquitoes that affects the liver.
-
NewsAccessible imaging technique can predict cardiac risks in patients with Chagas disease
A simple imaging exam capable of assessing myocardial deformation during contraction has emerged as a promising tool for predicting the risk of cardiac complications in patients with chronic Chagas disease.
-
NewsPlasma strategy boosts antibacterial efficacy of silica-based materials
Scientists have developed a novel two-step plasma strategy to modify mesoporous silica-supported silver nanoparticles, enabling them to achieve strong antibacterial activity and accelerated wound healing.
-
NewsResearch finds higher rare risk of heart complications in children after COVID-19 infection than after vaccination
A whole-population study showed that although these conditions were rare, children and young people were more likely to experience heart, vascular or inflammatory problems after a COVID-19 infection than after having the vaccine — and the risks after infection lasted much longer.
-
News‘Rotten egg’ gas could be the answer to treating nail infections, say scientists
Hydrogen sulphide, the volcanic gas that smells of rotten eggs, could be used in a new treatment for tricky nail infections that acts faster but with fewer side effects, according to scientists.
-
NewsStudy reveals critical impact of universal cCMV screening on early detection of hearing loss in newborns
A comprehensive eight-year study reveals that approximately one-third of congenital cytomegalovirus-related hearing loss develops after the newborn period—cases that would be missed without universal screening programs.
-
NewsMyths about rapid spread of the Black Death influenced by single ‘literary tale’, experts show
Modern portrayals of the Black Death quickly moving across Asia, ravaging Silk Route communities, following the course of traders, have been incorrect because of centuries of misinterpretation of a rhyming fourteenth-century literary tale, experts have found.
-
NewsAdvanced disease modelling shows some gut bacteria can spread as rapidly as viruses
Escherichia coli (E. coli), a type of bacteria commonly found in the human gut, could spread as quickly as swine flu, new research suggests. For the first time, researchers are able to predict the rate at which one person could transmit gut bacteria to those around them.
-
NewsBreathing new life Into TB treatment with inhalable nanomedicine
Scientists are developing an inhalable nanosystem to transport TB medicines directly into the lungs, the very place where the bacterium that causes TB hides and thrives. The nanocarrier can hold all four standard TB drugs in a single formulation and release them precisely at the infection site.
-
NewsBiomaterial vaccines to make implanted orthopedic devices safer
Biomaterial vaccines using pathogen-specific antigens could significantly lower patients’ risk of infection from implanted medical devices.